Location History:
- Springfield, NJ (US) (2017)
- Keasbey, NJ (US) (2023)
Company Filing History:
Years Active: 2017-2023
Title: Innovations by Ashwin Basarkar
Introduction
Ashwin Basarkar is a notable inventor based in Springfield, NJ (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of stable formulations for therapeutic antibodies. With a total of 2 patents, his work has the potential to impact cancer treatment and biopharmaceutical production.
Latest Patents
One of Ashwin Basarkar's latest patents is focused on stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereof. This invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof. The formulations typically comprise between 5-200 mg/mL of anti-PD-1 antibody, or its antigen binding fragment. Furthermore, the invention provides methods for treating various cancers using these stable formulations, which can be administered to a subject via intravenous or subcutaneous routes.
Another significant patent by Basarkar involves liquid formulations for TNFR:Fc fusion proteins. This invention provides stable liquid formulations for a recombinant biopharmaceutical protein that includes a soluble form of the human p75 TNF receptor fused to an Fc domain of a human immunoglobulin protein (TNFR:Fc). The development of such formulations is crucial for ensuring the consistent and reproducible quality of biopharmaceutical products, which are often produced using recombinant DNA technology in mammalian cell expression systems.
Career Highlights
Ashwin Basarkar is currently employed at Merck Sharp & Dohme Corporation, where he continues to innovate in the field of biopharmaceuticals. His work is characterized by a commitment to improving the efficacy and safety of therapeutic proteins.
Collaborations
Throughout his career, Ashwin has collaborated with talented individuals such as Ramesh Kashi and Sarita Mittal. These collaborations have likely contributed to the success of his innovative projects.
Conclusion
Ashwin Basarkar's contributions to the field of biopharmaceuticals through his patents on stable formulations of antibodies and fusion proteins highlight his role as a significant inventor. His work not only advances cancer treatment but also enhances the quality of biopharmaceutical products.